These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

967 related articles for article (PubMed ID: 27984723)

  • 1. In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.
    Ocampo A; Reddy P; Martinez-Redondo P; Platero-Luengo A; Hatanaka F; Hishida T; Li M; Lam D; Kurita M; Beyret E; Araoka T; Vazquez-Ferrer E; Donoso D; Roman JL; Xu J; Rodriguez Esteban C; Nuñez G; Nuñez Delicado E; Campistol JM; Guillen I; Guillen P; Izpisua Belmonte JC
    Cell; 2016 Dec; 167(7):1719-1733.e12. PubMed ID: 27984723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Aging Strategies Based on Cellular Reprogramming.
    Ocampo A; Reddy P; Belmonte JCI
    Trends Mol Med; 2016 Aug; 22(8):725-738. PubMed ID: 27426043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice.
    Browder KC; Reddy P; Yamamoto M; Haghani A; Guillen IG; Sahu S; Wang C; Luque Y; Prieto J; Shi L; Shojima K; Hishida T; Lai Z; Li Q; Choudhury FK; Wong WR; Liang Y; Sangaraju D; Sandoval W; Esteban CR; Delicado EN; Garcia PG; Pawlak M; Vander Heiden JA; Horvath S; Jasper H; Izpisua Belmonte JC
    Nat Aging; 2022 Mar; 2(3):243-253. PubMed ID: 37118377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprogramming progeria fibroblasts re-establishes a normal epigenetic landscape.
    Chen Z; Chang WY; Etheridge A; Strickfaden H; Jin Z; Palidwor G; Cho JH; Wang K; Kwon SY; Doré C; Raymond A; Hotta A; Ellis J; Kandel RA; Dilworth FJ; Perkins TJ; Hendzel MJ; Galas DJ; Stanford WL
    Aging Cell; 2017 Aug; 16(4):870-887. PubMed ID: 28597562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency.
    van den Hurk M; Kenis G; Bardy C; van den Hove DL; Gage FH; Steinbusch HW; Rutten BP
    Epigenomics; 2016 Aug; 8(8):1131-49. PubMed ID: 27419933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rejuvenation by Partial Reprogramming of the Epigenome.
    Mendelsohn AR; Larrick JW; Lei JL
    Rejuvenation Res; 2017 Apr; 20(2):146-150. PubMed ID: 28314379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming.
    Chondronasiou D; Gill D; Mosteiro L; Urdinguio RG; Berenguer-Llergo A; Aguilera M; Durand S; Aprahamian F; Nirmalathasan N; Abad M; Martin-Herranz DE; Stephan-Otto Attolini C; Prats N; Kroemer G; Fraga MF; Reik W; Serrano M
    Aging Cell; 2022 Mar; 21(3):e13578. PubMed ID: 35235716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue damage and senescence provide critical signals for cellular reprogramming in vivo.
    Mosteiro L; Pantoja C; Alcazar N; Marión RM; Chondronasiou D; Rovira M; Fernandez-Marcos PJ; Muñoz-Martin M; Blanco-Aparicio C; Pastor J; Gómez-López G; De Martino A; Blasco MA; Abad M; Serrano M
    Science; 2016 Nov; 354(6315):. PubMed ID: 27884981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig.
    Choi KH; Park JK; Son D; Hwang JY; Lee DK; Ka H; Park J; Lee CK
    PLoS One; 2016; 11(6):e0158046. PubMed ID: 27336671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of Fibrosis and Scar Formation by Partial Reprogramming In Vivo.
    Doeser MC; Schöler HR; Wu G
    Stem Cells; 2018 Aug; 36(8):1216-1225. PubMed ID: 29761584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
    Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
    Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor-mediated reprogramming: epigenetics and therapeutic potential.
    Firas J; Liu X; Lim SM; Polo JM
    Immunol Cell Biol; 2015 Mar; 93(3):284-9. PubMed ID: 25643615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular trajectories and molecular mechanisms of iPSC reprogramming.
    Apostolou E; Stadtfeld M
    Curr Opin Genet Dev; 2018 Oct; 52():77-85. PubMed ID: 29925040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial reprogramming as a therapeutic approach for heart disease: A state-of-the-art review.
    Talkhabi M
    J Cell Biochem; 2019 Sep; 120(9):14247-14261. PubMed ID: 31081174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling epigenetic regulation in cancer, aging, and rejuvenation with in vivo reprogramming technology.
    Sogabe Y; Seno H; Yamamoto T; Yamada Y
    Cancer Sci; 2018 Sep; 109(9):2641-2650. PubMed ID: 29989289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Transient and Partial Cell Reprogramming to Pluripotency as a Therapeutic Tool for Neurodegenerative Diseases.
    Tamanini S; Comi GP; Corti S
    Mol Neurobiol; 2018 Aug; 55(8):6850-6862. PubMed ID: 29353456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells.
    Heng JC; Feng B; Han J; Jiang J; Kraus P; Ng JH; Orlov YL; Huss M; Yang L; Lufkin T; Lim B; Ng HH
    Cell Stem Cell; 2010 Feb; 6(2):167-74. PubMed ID: 20096661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sox2 and Klf4 as the Functional Core in Pluripotency Induction without Exogenous Oct4.
    An Z; Liu P; Zheng J; Si C; Li T; Chen Y; Ma T; Zhang MQ; Zhou Q; Ding S
    Cell Rep; 2019 Nov; 29(7):1986-2000.e8. PubMed ID: 31722212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular signature defining exercise adaptation with ageing and in vivo partial reprogramming in skeletal muscle.
    Jones RG; Dimet-Wiley A; Haghani A; da Silva FM; Brightwell CR; Lim S; Khadgi S; Wen Y; Dungan CM; Brooke RT; Greene NP; Peterson CA; McCarthy JJ; Horvath S; Watowich SJ; Fry CS; Murach KA
    J Physiol; 2023 Feb; 601(4):763-782. PubMed ID: 36533424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of small molecules on cell reprogramming.
    Baranek M; Belter A; Naskręt-Barciszewska MZ; Stobiecki M; Markiewicz WT; Barciszewski J
    Mol Biosyst; 2017 Jan; 13(2):277-313. PubMed ID: 27918060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.